Search
Adagene Inc
ADAGAdd to Watchlist
4.470USD
-0.310-6.49%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
211.81MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-6.49%
5 Days
+6.68%
1 Month
+24.86%
6 Months
+142.93%
Year to Date
+136.51%
1 Year
+141.62%
Key Figures
4.650Open
4.780High
81.65KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.17%Turnover Ratio
4.780Prev. Close
4.408Low
266.84KTurnover
LossP/E Static
5.99P/B
0.00%Div Yield TTM
-35.73%ROA
4.75052wk High
0.28Volume Ratio
-33.42MNet Profit
47.39MShares
-0.5145EPS TTM
0.59Beta
-63.26%ROE
1.30052wk Low
7.78%Amplitude
--Gross Margin
211.81MMarket Cap
5.34Reward/Risk
6.27%Risk Rate
TradingKey Stock Score
No stock score available due to insufficient data.
Adagene Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Adagene Inc Info
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. The Company is principally engaged in the research, development and production of monoclonal antibody drugs for cancers. The Company’s main products include: ADG106 is being developed for the treatment of advanced solid tumors and non-Hodgkin's lymphoma, or NHL. ADG126 is designed to address the toxicity and efficacy issues related to the MOA of existing approved CTLA-4 immuno-oncology therapies and to expand the potential of CTLA-4 as a target for the treatment of cancer. ADG116 is designed to target a unique conserved epitope of CTLA-4. And ADG104, a monospecific antibody that targets PD-L1 and is in Phase Ib and Phase II clinical trials concurrently in China.
Ticker SymbolADAG
CompanyAdagene Inc
CEOLuo (Peter)
Websitehttps://www.adagene.com/
Related Instruments
+1.62%
+3.50%
+6.14%
+3.96%
+3.31%
+3.72%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+4.11%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Adagene Inc (ADAG)?
The current price of Adagene Inc (ADAG) is 4.47.
What is the symbol of Adagene Inc?
The ticker symbol of Adagene Inc is ADAG.
What is the 52-week high of Adagene Inc?
The 52-week high of Adagene Inc is 4.75.
What is the 52-week low of Adagene Inc?
The 52-week low of Adagene Inc is 1.30.
What is the market capitalization of Adagene Inc?
The market capitalization of Adagene Inc is 211.81M.
Is Adagene Inc (ADAG) currently rated as Buy, Hold, or Sell?
According to analysts, Adagene Inc (ADAG) has an overall rating of Buy, with a price target of 11.18.
What is the Earnings Per Share (EPS TTM) of Adagene Inc (ADAG)?
The Earnings Per Share (EPS TTM) of Adagene Inc (ADAG) is -0.37.